“。。。。。。 Yes sir, our bid reserve price is $3 billion, and if we are sure to participate in the bid, we must deposit $100 million into our designated account by August 1st!"

。。。。。。

"Yes sir, these are the conditions that have been determined!"

。。。。。。

"Thank you very much and look forward to seeing you again, goodbye!"

After putting down the microphone, Qian Lele couldn't help but let out a long breath, and his heart suddenly felt relaxed: "It's finally all noticed, it's really not easy!"

In the second week after looking at the land of Kyoto Pharmaceutical, that is, on the morning of the day when Tian Lu came to the Future Biology Building every week, the three giants of the Future Biology Laboratory got together and set the reserve price and the amount of the deposit for the bidding meeting, and while Tian Lu was present, Qian Lele immediately called the contacts of the eight pharmaceutical companies and sent a fax, which was the final decision.

"It seems that everyone probably has an opinion!"

After listening to all the phone calls, Han Jun said with some uneasiness.

"Yes, yes. ”

Regarding Han Jun's worries, Tian Lu smiled a little disappreciatively: "The reserve price of three billion US dollars is far beyond the final transaction amount of the three patents in the last bidding meeting, and they will naturally not be very happy, after all, this means that no matter which company wins in the end, it will pay a huge price!"

"But this time, after all, it's a transfer of ownership of all patents!"

Qian Lele said with some doubts: "And the market size of the drug, as well as the performance and value of the drug, don't you need to consider? Look at Kyoto Pharmaceutical, just the preliminary preparation is already 5 billion US dollars, are those multinational giants not as good as our domestic pharmaceutical company?"

"Well, how can you compare that?"

Tian Lu smiled bitterly and shook his head.

"yes, the two are different concepts. ”

Han Jun also nodded: "First of all, the urgency of those multinational giants for new patents is definitely not up to the level of Kyoto Pharmaceutical, after all, they all have their own patented drugs, and they also have internationally leading drug research and development experience and achievements, so they may not be able to invest such a huge amount of money in our new product." To know. The reserve price is $3 billion. Then the final transaction price will probably be at least doubled, which is quite a huge number for any giant!"

"Besides, it's not like you don't know that Kyoto Medicine's quotation also has a lot of moisture. ”

Tian Lu smiled. Then he added, "Whether it's the price of the land or the price of the shares of the Kyoto Pharmaceutical Group. They all took a big advantage. It's just that because these two happen to be things that our lab urgently needs, we deliberately give them too much, after all, their strength is too weak. It's even far from Great Wall Medicine, and if we really take it seriously, it means that we have given up on these two things. ”

For the future biological laboratory, Kyoto Pharmaceutical Group may indeed be the best choice.

The allure of land is self-evident, and the shares are also attractive enough! Although there is a slight amount of moisture in value, don't forget that if Future Biotech takes a patent as a shareholder, the sales share of the future patent will be calculated according to the share share!

Otherwise, how could the two possibly calculate such a figure as five billion dollars?

shares, after the land is removed, the total capital of Kyoto Pharmaceutical Group is only more than 20 billion Chinese dollars, that is, 4 billion US dollars, even if the future biological investment increases, 40% of the shares, it will only be more than 2 billion US dollars, and it will be even lower. However, Tian Lu still gave a converted price of three billion according to Meng Yun's offer.

As for the land, although it is much better than the plots used to run factories, it will definitely not reach Meng Yun's offer, after all, it is not too close to the city and cannot be sold at a particularly high price, but in the end, after repeated measurements, Tian Lu still agreed to Meng Yun's offer, two billion US dollars, which is equivalent to nearly nine hundred US dollars per square meter, almost six thousand Chinese dollars!

This price is enough to make Kyoto Medicine ecstatic.

In fact, just yesterday, when Qian Lele informed Meng Yun of the final amount of cash converted between the two, the other party was also stunned for a while, and then he was overjoyed! You must know that although the low price in Kyoto is high, it can only be sold at a high price in the bustling urban area, and a location like this will definitely not be too expensive. Although he quoted a high price at the beginning, Meng Yun was already ready for the other party to slash hard!

So after getting Tian Lu's offer, Meng Yun immediately realized that Tian Lu really intended to hand over the patent to Kyoto Medicine this time!

Indeed, after a week of consideration, all three of them were already faintly inclined to choose Kyoto Pharmaceutical Group.

Such a large plot of land can be met but not sought, and in Tian Lu's opinion, it is definitely possible to sacrifice some cash income for it. It is impossible for any other multinational giant to pay the price of shares, and Great Wall Pharmaceutical Group may be able to, but it will definitely not give so much, and it is also worth sacrificing some cash income to be able to hold so many shares of a large pharmaceutical group company.

It's just that the sacrifice of more than a billion dollars is indeed a bit big.

So Qian Lele is a little unhappy with this price, she is still worried about the future demand for funds, if she really can't get enough cash by then, then even if she gets the more than 3,000 acres of land, what's the use?

Seeing Qian Lele's concerns, Tian Lu leaned over and said with a smile: "Don't worry, this time will be different from the last bidding, the results of half a year's evaluation can be said to be beyond our imagination, and there is such a huge market, they won't be able to see it! I think our new patent should be more than five billion US dollars, even if Kyoto Medicine wants to get it, I'm afraid it will pay more price。。。。。。

。。。。。。

After issuing a notice to all pharmaceutical companies eligible to participate in the bidding, Han Jun and Qian Lele worked together. Meticulous preparations began for the bidding session in August.

For the future biological laboratory, although the bidding meeting has rules to follow, this bidding meeting is much more important than the one in two or three years, and it is likely to be related to the laboratory's future scientific research base and drug research and development strategy, so both Han Jun and Qian Lele have paid enough attention to it, and the preparations must be the most meticulous, and there must be no mistakes.

As for Tian Lu, it's still the same, and I'm back in the hospital to be busy.

The use of neural stem cells in neurosurgery has been going on for a long time. Many top neurosurgeons at home and abroad have even had a considerable degree of application experience. It's just that for the Department of Neurosurgery of the Second Affiliated Hospital, this is indeed the first time that a big girl has been on a sedan chair.

Although Tian Lu has more "experience" in this area than anyone else because of the function of the system to simulate surgery, it is in order to meet the needs of all aspects of reality. At the same time, it is also to give all the members of the two groups a space to learn and grow. The field road must start from the basics. Establish a systematic and scientific process.

In the future bio building, the preparation of neural stem cells and even the preparation of directional differentiation and other aspects have been completed, but in the clinic. Even though Tian Lu is 100% sure, he still has to start with the task of the laboratory stage, starting from the establishment of in vitro models, and then using those cute experimental animals to conduct animal experiments before clinical application!

It's a must-have process.

The laboratory specially established for the stem cell team has received a complete set of equipment from the Future Biology Laboratory very early, and six scientific researchers plus Tian Lu and even Huang Qiaoqiao have been in the hospital every day for a period of time, making sufficient preparations for Tian Lu's first neural stem cell surgery。。。。。。。

This is the only topic that Tian Lu is planning to do on his own in the past two years!

Although two teams have been established to specialize in the clinical application of stem cells, the foundation of the six or seven doctors is too thin, and the accumulation of neurosurgery in this area is almost zero.

Fortunately, for Tian Lu, such a thing is not that difficult.

Just like the Department of Neurosurgery has been investing a lot of energy in the past few years, the Department of Neurosurgery has been investing a lot in the standardized diagnosis and treatment of neurosurgery, in this hot June, July and August, a series of related articles with the Second Affiliated Hospital of Beijing Normal University as the first author unit have been published one after another!

Articles on the standard diagnosis and treatment of epilepsy surgery and neurosurgery have been published in the neurosurgery section of BMJ as a continuation of the previous practice, while articles in other areas of functional neurosurgery, at the discretion of each task group, will either continue to be published in the same journal or in a different way and published in a more authoritative journal that they prefer.

In any case, in this hot summer, the neurosurgery department of the Second Affiliated Hospital once again set off a big storm!

As the corresponding author of all papers, Tian Lu's name has once again become the focus of the neurosurgery community, because at the same time, the cooperative research on the conventional treatment of drugs in several fields has also reached a stage, and the relevant results have been released, and even in the neurology community, the name has become louder and louder!

Maybe those studies were not carried out by Tian Lu himself, and even the dominant position was also given up, but it is undeniable that the starting point of these studies, even including the specific scientific research design scheme, came from Tian Lu, so when the article is published, no article will miss this important name!

It's just that this time it didn't cause any trouble to Tian Lu.

I don't know when it started, but before you know it, everyone has become accustomed to Tian Lu's name frequently appearing in those top journals in the field of neuroscience。。。。。。

。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。

During the National Day, there may be fewer updates, so I can only do my best!

You probably have also seen that these chapters seem to be a little messy and a little watery recently, and this is because I am trolling through the previous plot and then filling in all kinds of holes.

The rest of the book is to focus on the main line, after all, the more difficult it is to write the further you go, and I will try my best to write it well. (To be continued.) )